During the past decade, Delaware Clinical and Laboratory Physicians PA conducted 110 clinical trials. In the 10-year time frame, 110 clinical trials started and 66 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 56 clinical trials were completed. i.e. 130.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Delaware Clinical and Laboratory Physicians PA" #1 sponsor was "National Cancer Institute (NCI)" with 75 trials, followed by "Alliance for Clinical Trials in Oncology" with 26 trials sponsored, "SWOG Cancer Research Network" with 26 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "Gynecologic Oncology Group" with 16 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Delaware Clinical and Laboratory Physicians PA" #1 collaborator was "National Cancer Institute (NCI)" with 86 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Delaware Clinical and Laboratory Physicians PA" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Invasive Breast Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Lymphoma" (6 trials) and "Stage IIIA Breast Cancer" (6 trials). Many other conditions were trialed in "Delaware Clinical and Laboratory Physicians PA" in a lesser frequency.

Most popular intervention types in "Delaware Clinical and Laboratory Physicians PA" are "Drug" (133 trials), "Other" (110 trials), "Biological" (66 trials), "Procedure" (43 trials) and "Radiation" (25 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (57 trials), "Quality-of-Life Assessment" (44 trials), "Questionnaire Administration" (26 trials), "Carboplatin" (21 trials) and "Cisplatin" (20 trials). Other intervention names were less common.

The vast majority of trials in "Delaware Clinical and Laboratory Physicians PA" are 141 trials for "All" genders, 24 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Delaware Clinical and Laboratory Physicians PA". undefined are not yet recruiting, 38 are recruiting, 82 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Delaware Clinical and Laboratory Physicians PA, 6 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Delaware Clinical and Laboratory Physicians PA, 4 "Phase 1" clinical trials were conducted, 86 "Phase 2" clinical trials and 82 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".